Literature DB >> 27868025

A sensible approach to targeting STAT3-mediated transcription.

Neil E Bhola1, Daniel E Johnson1, Jennifer R Grandis1.   

Abstract

Entities:  

Year:  2016        PMID： 27868025      PMCID： PMC5104644          DOI： 10.21037/atm.2016.10.51

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  20 in total

Review 1.  Stat proteins and oncogenesis.

Authors:  Jacqueline Bromberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Recognizing and exploiting differences between RNAi and small-molecule inhibitors.

Authors:  William A Weiss; Stephen S Taylor; Kevan M Shokat
Journal:  Nat Chem Biol       Date:  2007-12       Impact factor: 15.040

3.  A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells.

Authors:  Hui Song; Renxiao Wang; Shaomeng Wang; Jiayuh Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

Review 4.  Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism.

Authors:  Chengguang Zhao; Huameng Li; Huey-Jen Lin; Shulin Yang; Jiayuh Lin; Guang Liang
Journal:  Trends Pharmacol Sci       Date:  2015-11-12       Impact factor: 14.819

5.  Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Priyanka Duttagupta; Dayson Moreira; Xingli Zhao; Haejung Won; Ralf Buettner; Sergey Nechaev; Marcin Majka; Bin Zhang; Qi Cai; Piotr Swiderski; Ya-Huei Kuo; Stephen Forman; Guido Marcucci; Marcin Kortylewski
Journal:  Blood       Date:  2016-01-21       Impact factor: 22.113

6.  Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide--interference with interferon-gamma-STAT1-mediated killing.

Authors:  Ali Tadlaoui Hbibi; Christelle Laguillier; Inès Souissi; Denis Lesage; Stéphanie Le Coquil; An Cao; Valeri Metelev; Fanny Baran-Marszak; Remi Fagard
Journal:  FEBS J       Date:  2009-03-16       Impact factor: 5.542

7.  AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.

Authors:  David Hong; Razelle Kurzrock; Youngsoo Kim; Richard Woessner; Anas Younes; John Nemunaitis; Nathan Fowler; Tianyuan Zhou; Joanna Schmidt; Minji Jo; Samantha J Lee; Mason Yamashita; Steven G Hughes; Luis Fayad; Sarina Piha-Paul; Murali V P Nadella; Morvarid Mohseni; Deborah Lawson; Corinne Reimer; David C Blakey; Xiaokun Xiao; Jeff Hsu; Alexey Revenko; Brett P Monia; A Robert MacLeod
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

8.  A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Authors:  Inès Souissi; Patrick Ladam; Jean A H Cognet; Stéphanie Le Coquil; Nadine Varin-Blank; Fanny Baran-Marszak; Valeri Metelev; Remi Fagard
Journal:  Mol Cancer       Date:  2012-03-16       Impact factor: 27.401

9.  Jak2-Independent Activation of Stat3 by Intracellular Angiotensin II in Human Mesangial Cells.

Authors:  Rekha Singh
Journal:  J Signal Transduct       Date:  2011-09-12

10.  Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression.

Authors:  Guangchao Li; Likun Zhao; Wei Li; Kexing Fan; Weizhu Qian; Sheng Hou; Hao Wang; Jianxin Dai; Huafeng Wei; Yajun Guo
Journal:  Oncotarget       Date:  2014-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.